You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 12, December 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Obesity
 •Statistics and Research Methods
 •Psoriasis
 •Public Health
 •Alert me on articles by topic

COMMENTS AND OPINIONS
The Skinny on Psoriasis and Obesity

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Obesity seems to be common in patients with psoriasis. The relationship is somewhat unclear, although in our experience, many patients at our clinic have some degree of obesity. Furthermore, recent trials of biologic therapy for treatment of psoriasis have commonly enrolled subjects with weights in excess of 90 kg (198 lb). Evidence for a link between psoriasis and obesity exists: medications developed for patients with diabetes mellitus are undergoing clinical trials for patients with psoriasis,1 and dietary modification can improve symptoms of psoriasis.2-3 Finally, patients with psoriasis and those who are obese share certain comorbidities, such as type 2 diabetes mellitus, dyslipidemia, hypertension, and cardiovascular disease.4

There are little data describing the true prevalence of obesity in patients with psoriasis. We tested the hypothesis that obesity is more common in patients with psoriasis by analyzing 2 nationally representative data sets: the 2000 Medical Expenditure Panel Survey (MEPS) and 1992-2000 Medicare . . . [Full Text of this Article]


AUTHOR INFORMATION
Joseph W. McGowan, BS; Daniel J. Pearce, MD; John Chen, PhD; David Richmond, PhD; Rajesh Balkrishnan, PhD; Steven R. Feldman, MD, PhD



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Etanercept Treatment for Children and Adolescents with Plaque Psoriasis
Paller et al.
NEJM 2008;358:241-251.
ABSTRACT | FULL TEXT  

Risk of myocardial infarction in patients with psoriasis.
Gelfand et al.
JAMA 2006;296:1735-1741.
ABSTRACT | FULL TEXT  

Obesity, Smoking, and Psoriasis
Lebwohl and Callen
JAMA 2006;295:208-210.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.